FibroGenFGEN
那斯達克 · USD
6.97
+0.05
(+0.72%)
盤中 08/02 12:25 (UTC+8)
08/02 12:25 (UTC+8)
FibroGenFGEN
6.97
+0.05
(+0.72%)
財務數據
損益表
- 0.34
- 0.36
- 0.44
- 0.40
- 0.27
- 0.25
- 0.81
- 0.46
- -1.23
- 0.03
- 118.43
- 5.22
- 22.56
- -9.44
- -32.38
- -6.54
- 220.06
- -42.93
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 2,739 | -123,256 | 46,333 | 81,180 | 25,364 | 27,138 | 40,134 | 44,319 | 36,161 | 34,367 |
營業成本 | 252 | -20,666 | 5,296 | 9,588 | 21,343 | 5,407 | 4,242 | 5,708 | 3,491 | 4,925 |
營業毛利 | 2,487 | -102,590 | 41,037 | 71,592 | 4,021 | 21,731 | 35,892 | 38,611 | 32,670 | 29,442 |
營業費用 | - | -11,834 | 57,815 | 64,392 | 53,203 | 75,926 | 99,374 | 126,658 | 108,761 | 95,594 |
研發費用 | 9,175 | 1,486 | 21,708 | 36,009 | 36,489 | 51,703 | 61,194 | 95,478 | 74,486 | 61,628 |
推銷及管理費用 | 8,106 | -13,320 | 17,553 | 28,383 | 16,714 | 24,223 | 25,574 | 31,180 | 34,275 | 33,966 |
非經常性項目費用 | 126 | - | 18,554 | - | - | - | 12,606 | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -14,920 | -90,756 | -16,778 | 7,200 | -49,182 | -54,195 | -63,482 | -88,047 | -76,091 | -66,152 |
其他收入及費用 | 413 | - | 3,803 | -946 | 2,235 | 2,496 | 4,297 | 2,651 | 1,036 | 924 |
利息費用 | 2,257 | -6,527 | 4,995 | 7,687 | 2,092 | 5,068 | 5,023 | 3,069 | 2,372 | 1,119 |
稅前純益 | -16,764 | -84,925 | -17,970 | -1,433 | -49,039 | -56,767 | -64,208 | -88,465 | -77,427 | -66,347 |
所得稅 | 2 | -52 | 12 | -236 | 7 | 80 | 84 | -235 | 74 | 108 |
稅後純益 | 4,639 | 17,982 | -17,084 | -15,544 | -32,933 | -56,232 | -63,615 | -87,680 | -76,705 | -66,175 |
基本每股稅後盈餘(元) | 0.05 | 0.18 | -0.17 | -0.16 | -0.33 | -0.57 | -0.65 | -0.90 | -0.81 | -0.70 |
稀釋每股稅後盈餘(元) | 0.05 | 0.18 | -0.17 | -0.16 | -0.33 | -0.57 | -0.64 | -0.90 | -0.81 | -0.71 |
基本平均股數(千股) | 100954.00 | 100830.00 | 100515.00 | 99835.00 | 98982.00 | 98496.00 | 98245.00 | 97729.00 | 94691.00 | 94032.00 |
稀釋平均股數(千股) | 100954.00 | 100830.00 | 100515.00 | 99835.00 | 98982.00 | 98496.00 | 98245.00 | 97729.00 | 94691.00 | 94032.00 |
還原基本每股稅後盈餘(元) | 1.25 | 4.50 | -4.25 | -4.00 | -8.25 | -14.25 | -16.25 | -22.50 | -20.25 | -17.50 |
還原稀釋每股稅後盈餘(元) | 1.25 | 4.50 | -4.25 | -4.00 | -8.25 | -14.25 | -16.00 | -22.50 | -20.25 | -17.75 |
還原基本平均股數(千股) | 4,038 | 4,033 | 4,020 | 3,993 | 3,959 | 3,939 | 3,929 | 3,909 | 3,787 | 3,761 |
還原稀釋平均股數(千股) | 4,038 | 4,033 | 4,020 | 3,993 | 3,959 | 3,939 | 3,929 | 3,909 | 3,787 | 3,761 |
EBITDA(千元) | 7,224 | 11,755 | -11,337 | -7,699 | -31,308 | -50,616 | -57,969 | -83,260 | -71,983 | -62,481 |